Verano (OTCMKTS:VRNOF – Get Free Report) and Organigram Global (NASDAQ:OGI – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, valuation, institutional ownership, dividends, risk, analyst recommendations and earnings.
Profitability
This table compares Verano and Organigram Global’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Verano | -41.68% | -9.54% | -4.51% |
| Organigram Global | -9.99% | -16.91% | -11.43% |
Risk & Volatility
Verano has a beta of 0.87, meaning that its stock price is 13% less volatile than the S&P 500. Comparatively, Organigram Global has a beta of 1.52, meaning that its stock price is 52% more volatile than the S&P 500.
Analyst Ratings
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Verano | 1 | 0 | 0 | 1 | 2.50 |
| Organigram Global | 1 | 0 | 0 | 0 | 1.00 |
Institutional and Insider Ownership
9.0% of Verano shares are owned by institutional investors. Comparatively, 34.6% of Organigram Global shares are owned by institutional investors. 9.1% of Verano shares are owned by insiders. Comparatively, 0.1% of Organigram Global shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Valuation & Earnings
This table compares Verano and Organigram Global”s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Verano | $878.59 million | 0.52 | -$341.86 million | ($0.98) | -1.29 |
| Organigram Global | $185.07 million | 1.18 | -$17.70 million | ($0.11) | -14.73 |
Organigram Global has lower revenue, but higher earnings than Verano. Organigram Global is trading at a lower price-to-earnings ratio than Verano, indicating that it is currently the more affordable of the two stocks.
Summary
Verano beats Organigram Global on 7 of the 13 factors compared between the two stocks.
About Verano
Verano Holdings Corp. operates as a vertically integrated multi-state cannabis operator in the United States. The company engages in the cultivation, processing, wholesale, and retail distribution of cannabis in Arizona, Arkansas, Connecticut, Florida, Illinois, Maryland, Massachusetts, Michigan, Nevada, New Jersey, Ohio, Pennsylvania, and West Virginia. It offers cannabis products under the Encore, Avexia, MUV, Savvy, BITS, and Verano brands for medical and adult-use markets. The company is headquartered in Chicago, Illinois.
About Organigram Global
Organigram Holdings Inc., through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co., Edison JOLTS, Tremblant, and Laurentian brands. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative-based products to retailers and wholesalers for adult-use recreational cannabis. It sells its products through online, as well as consumer channels. The company was incorporated in 2010 and is headquartered in Toronto, Canada.
Receive News & Ratings for Verano Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Verano and related companies with MarketBeat.com's FREE daily email newsletter.
